Asia Business News | Tuesday, May 13, 2008
email news alerts
RSS 2.0  
 Ventracor is a global medical device company which produces an implantable blood pump, the VentrAssist left ventricular assist device (LVAD), as a therapy to improve the lives of heart failure patients. Ventracor is dedicated to building partnerships with healthcare professionals to make the VentrAssist the standard-of-care worldwide.
Company Principal Sector Health & Pharm 
Company Principal Industry Healthcare 
Company Homepage www.ventracor.com.au
 
Stock Exchange Stock Code
ASXVCR
ZOBEXVTR
ADR QUOTEVTCRY
PNKVTCRY
News Reader RSS   Ventracor Limited
 Ventracor Limited (ASX:VCR) Announce 250th Implant of VentrAssist Left Ventricular Assist Device (LVAD) (MAY 6, 2008)
 Ventracor Limited (ASX:VCR) Announce Results of US Feasibility Trial of the VentraAssist LVAD (APR 14, 2008)
 Ventracor Limited (ASX:VCR) CEO Peter Crosby Letter to Shareholders (APR 3, 2008)
 Ventracor Limited (ASX:VCR) Announce Election of John Ward to Chairman (APR 3, 2008)
 Ventracor (ASX:VCR) Announce US FDA Unconditional Approval of Destination Therapy Trial For LVAD (MAR 17, 2008)
 Ventracor Limited (ASX:VCR) Appoints Destination Therapy Trial Principal Investigator For LVAD (MAR 13, 2008)
 Ventracor Limited (ASX:VCR) Announces 200th VentraAssist LVAD (Left Ventricular Assist Device) Implant (FEB 11, 2008)
 Ventracor (ASX:VCR) Announces European Approval for New Version VentrAssist LVAD (DEC 19, 2007)
 Ventracor (ASX:VCR) To Use New LVAD In US Clinical Trial Program (DEC 18, 2007)
 Ventracor Limited (ASX: VCR) Announce Milestone with FDA Approval for Heart Pump (DEC 3, 2007)
 Ventracor Limited (ASX: VCR) Letter To Shareholders (NOV 22, 2007)
 Ventracor Growth Continues - 10 Active US Hospitals As Part Of US Clinical Trials (NOV 20, 2007)
 Ventracor (ASX: VCR) Announce 150 VentrAssist Implants Worldwide (OCT 5, 2007)
 Ventracor Announces FY2007 Results And Strong Revenue Growth on 64 LVAD Implants (AUG 16, 2007)
 Ventracor Launch US Pivotal Trial of VentrAssist (JUNE 6, 2007)
 Ventracor; Growing Global Momentum Results in Strong Revenue Growth (JUNE 5, 2007)
 Ventracor's Clinical Trial Programme In US Gaining Traction (MAY 29, 2007)
 Ventracor Appoints New Directors To Strenghten Board (MAY 2, 2007)
 Ventracor Limited Investor Update March 2007 (MAR 29, 2007)
Drag Podcast Icon To iTunes - Podcast Download for Ventracor Limited
 Ventracor Limited ASX: VCR - Full Year Results 2007 - Mr Peter Crosby, MD And CEO (AUG 17, 2007)